American International Group Changes Organizational Structure

American International Group Changes Organizational Structure

American International Group (AIG) said Monday that it is planning to make changes to its organizational structure, which aims to maximize its global platform by empowering its local geographies. The company said that it will no longer have Commercial and Consumer segments, and will transition to: General Insurance, led by Peter Zaffino, as CEO; Life & Retirement, led by Kevin Hogan, CEO; and a stand-alone, technology-enabled platform, led by Seraina […]

Read More ˃
NewLink Genetics, AstraZeneca To Study Drug Combination In Pancreatic Cancer Patients

NewLink Genetics, AstraZeneca To Study Drug Combination In Pancreatic Cancer Patients

NewLink Genetics (NLNK) said Monday it will collaborate with AstraZeneca (AZN) to evaluate the combination of indoximod and durvalumab along with standard of care chemotherapy in the treatment of metastatic pancreatic cancer. Indoximod is NewLink Genetics’ small molecule IDO pathway inhibitor and durvalumab is AstraZeneca’s anti-PD-L1 monoclonal antibody. Chemotherapy is the standard of care treatment. A placebo-controlled phase 2 study will evaluate the efficacy and safety of the drug combination […]

Read More ˃